A strategy to manage a known or potential serious risk associated with a drug or biological product.
Glossary
Risk Evaluation and Mitigation Strategy (REMS)
02.27.12
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Industry News
Worldwide Clinical Trials Appoints Clinical Ops VP
Nowatkoski brings extensive senior clinical operations
-
Clinical Trial Materials
CMO Selection Criteria
What should sponsors look for when outsourcing manufacture of material for first in human studies?Alastair Hay
-
-
REMS
...
